Important Update on Chikungunya Vaccines

Important Update: Ixchiq No Longer Approved for Use

We want to inform our valued customers that Ixchiq is no longer approved for use at this time. The FDA has suspended the license of IXCHIQ in the US. To learn more, please see the press release from Valneva here https://valneva.com/press-release/valneva-announces-fdas-decision-to-suspend-license-of-chikungunya-vaccine-ixchiq-in-the-u-s/

Introducing Vimkunya: Our New Offering

In light of this change, we are pleased to announce that we are now able to provide our patients with Vimkunya - a recombinant vaccine that is FDA approved for protection against Chikungunya. This alternative is available for purchase, but please note that pre-payment is required at this time. Vimkunya offers a reliable solution and we are excited to provide our customers with this new option. What To Know about Chikungunya Virus and Vaccine

For more information on Vimkunya or to place an order, please contact us. We appreciate your understanding and support as we navigate these changes.